original ) (raw )Cytotoxic T-Lymphocyte Responses to Human Papillomavirus Type 16 E5 and E7 Proteins and HLA-A*0201-Restricted T-Cell Peptides in Cervical Cancer Patients
岱瑋 劉
Journal of Virology, 2007
View PDFchevron_right
Human Papillomavirus Type 33 E7 Peptides Presented by HLA-DR*0402 to Tumor-Infiltrating T Cells in Cervical Cancer
Markus Maeurer
Journal of Virology, 2000
View PDFchevron_right
Circulating human papillomavirus type 16 specific T-cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts
Ekaterina Jordanova
International Journal of Cancer, 2007
View PDFchevron_right
HLA-A2-restricted peripheral blood cytolytic T lymphocyte response to HPV type 16 proteins E6 and E7 from patients with neoplastic cervical lesions
Klaus Heeg
Cancer Immunology, Immunotherapy, 1996
View PDFchevron_right
The detection of circulating human papillomavirus-specific T cells is associated with improved survival of patients with deeply infiltrating tumors
Gert Fleuren
International Journal of Cancer, 2011
View PDFchevron_right
Papillomavirus-E7 Peptides Provided by Human Recognize HLA-DR-Restricted Lymphocytes in Cervical Cancer Tumor-Infiltrating + CD4
Markus Maeurer
2010
View PDFchevron_right
Expression of CD56 by human papillomavirus E7-specific CD8+ cytotoxic T lymphocytes correlates with increased intracellular perform expression and enhanced cytotoxicity against HLA-A2-matched cervical tumor cells
Stefania Bellone
Clinical Cancer Research, 2001
View PDFchevron_right
Cervical Cancer-Associated Human Papillomavirus 16 E7 Oncoprotein Inhibits Induction of Anti-Cancer Immunity by a CD4+ T Cell Dependent Mechanism
Germain J P Fernando
Nature Precedings, 2009
View PDFchevron_right
Antitumor Activity of Human Papillomavirus Type 16 E7-Specific T Cells against Virally Infected Squamous Cell Carcinoma of the Head and Neck
Andreas Albers
Cancer Research, 2005
View PDFchevron_right
Association of cervical cancer with the presence of CD4 + regulatory T cells specific for human papillomavirus antigens
Marij Welters
Proceedings of the National Academy of Sciences, 2007
View PDFchevron_right
A Conserved E7-derived Cytotoxic T Lymphocyte Epitope Expressed on Human Papillomavirus 16-transformed HLA-A2+ Epithelial Cancers
Karen Anderson
Journal of Biological Chemistry, 2010
View PDFchevron_right
Disease-Stage Variance in Functional CD4+ T-Cell Responses Against Novel Pan-Human Leukocyte Antigen-D Region Presented Human Papillomavirus-16 E7 Epitopes
W. Martin Kast
Clinical Cancer Research, 2004
View PDFchevron_right
Expression of CD56 by Human Papillomavirus E7-specific CD8+ Cytotoxic T Lymphocytes Correlates with Increased Intracellular Perforin Expression and Enhanced Cytotoxicity against HLA-A2-matched Cervical Tumor Cells
Stefania Bellone
Clinical Cancer Research, 2001
View PDFchevron_right
Detection of T Helper Responses, But Not of Human Papillomavirus-Specific Cytotoxic T Lymphocyte Responses, After Peptide Vaccination of Patients With Cervical Carcinoma
Martin Kast
Journal of Immunotherapy, 2000
View PDFchevron_right
Human papilloma virus specific immunogenicity and dysfunction of CD8+ T cells in head and neck cancer
Seunghee Schulze
Cancer research, 2018
View PDFchevron_right
Human papillomavirus-specific cytotoxic T lymphocytes in patients with cervical intraepithelial neoplasia grade III
Mercy Nimako
Cancer research, 1997
View PDFchevron_right
Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells
Daphne Jansen , Mariet Feltkamp , Martin Kast
European Journal of Immunology, 1993
View PDFchevron_right
Cellular immunity against human papillomavirus associated cervical cancer
Remco Brandt , Martin Kast
Seminars in Virology, 1996
View PDFchevron_right
An exploration of the natural and acquired immunological mechanisms to high-risk human papillomavirus infection and unmasking immune escape in cervical cancer: A concise synopsis
Prof.dr.zaytoon alkhafaji
Published by Wolters Kluwer - Medknow, 2025
View PDFchevron_right
Human Papillomavirus Type 16-Positive Cervical Cancer Is Associated with Impaired CD4+ T-Cell Immunity against Early Antigens E2 and E6
Gert Fleuren
Cancer Research, 2004
View PDFchevron_right
CD4+ T cells against human papillomavirus-18 E7 in patients with high-grade cervical lesions associate with the absence of the virus in the cervix
Simone Vantini
Immunology, 2000
View PDFchevron_right
Potential value of in situ cellular immune response in HPV subtype 16 and 18 positive cervical cancer
Stefan Butureanu
Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie, 2014
View PDFchevron_right
Impact of human papilloma virus HPV on immunosenescent CD57+ T-lymphocytes in cervical cancer patients
Ahmed Ghareeb
Microbial Biosystems
View PDFchevron_right
Infiltrating CD4 and CD8 lymphocytes in HPV infected uterine cervical milieu
muna maharjan
Cancer Management and Research
View PDFchevron_right